Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

NCT00731029 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Thiomersal free trivalent influenza split vaccine 2002/2003
BIOLOGICAL: GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2002/2003

Sponsor

GlaxoSmithKline